Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission

Journal of Neurochemistry

Volumn , Issue , 2016, Pages 254-264

  Beggiato, Sarah ^a,b   Tomasini, Maria Cristina ^a,b   Borelli, Andrea Celeste ^a   Borroto Escuela, Dasiel Oscar ^c   Fuxe, Kjell ^c   Antonelli, Tiziana ^a,b   Tanganelli, Sergio ^a,b   Ferraro, Luca ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b IRET Foundation   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CGS21680; CHPG; extracellular GABA and glutamate levels; Parkinson's disease; quinpirole; receptor heteromers

Indexed keywords

2 CHLORO 5 HYDROXYPHENYLGLYCINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR 5; QUINPIROLE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; GABAERGIC TRANSMISSION; GLOBUS PALLIDUS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84979010983     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13652     Document Type: Article

References (41)

1. Agnati L. F., Ferre S., Lluis C., Franco R. and Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509–550.
2. Andersen S. L. and Gazzara R. A. (1994) The development of D2 autoreceptor-mediated modulation of K(+)-evoked dopamine release in the neostriatum. Brain Res. Dev. Brain Res. 78, 123–130.
3. Armentero M. T., Pinna A., Ferré S., Lanciego J. L., Müller C. E. and Franco R. (2011) Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol. Ther. 132, 280–299.
4. Beggiato S., O'Connor W. T., Tomasini M. C., Antonelli T., Loche A., Tanganelli S., Cacciaglia R. and Ferraro L. (2013a) GET73 increases rat extracellular hippocampal CA1 GABA levels through a possible involvement of local mGlu5 receptor. Synapse 67, 678–691.
5. Beggiato S., Antonelli T., Tomasini M. C., Tanganelli S., Fuxe K., Schwarcz R. and Ferraro L. (2013b) Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo. Eur. J. Neurosci. 37, 1470–1477.
6. Borroto-Escuela D. O., Tarakanov A. O., Guidolin D., Ciruela F., Agnati L. F. and Fuxe K. (2011) Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration. IUBMB Life 63, 463–472.
7. Cabello N., Gandía J., Bertarelli D. C., Watanabe M., Lluís C., Franco R., Ferré S., Luján R. and Ciruela F. (2009) Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J. Neurochem. 109, 1497–1507.
8. Canela L., Selga E., García-Martínez J. M. et al. (2012) Transcriptional profiling of striatal neurons in response to single or concurrent activation of dopamine D2, adenosine A(2A) and metabotropic glutamate type 5 receptors: focus on beta-synuclein expression. Gene 508, 199–205.
9. Ciruela F., Fernández-Dueñas V., Llorente J., Borroto-Escuela D. O., Cuffí M. L., Carbonell L., Sánchez S., Agnati L. F., Fuxe K. and Tasca C. I. (2012) G protein-coupled receptor oligomerization and brain integration: focus on adenosinergic transmission. Brain Res. 1476, 86–95.
10. Coleman C. G., Baghdoyan H. A. and Lydic R. (2006) Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. J. Neurochem. 96, 1750–1759.
11. Díaz-Cabiale Z., Vivó M., Del Arco A., O'Connor W. T., Harte M. K., Müller C. E., Martínez E., Popoli P., Fuxe K. and Ferré S. (2002) Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Neurosci. Lett. 324, 154–158.
12. Doherty A. J., Palmer M. J., Henley J. M., Collingridge G. L. and Jane D. E. (1997) (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36, 265–267.
13. Fazal A., Parker F., Palmer A. M. and Croucher M. J. (2003) Characterisation of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices. J. Neurochem. 86, 1346–1358.
14. Ferraro L., Antonelli T., O'Connor W. T., Fuxe K., Soubrié P. and Tanganelli S. (1998) The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J. Neurosci. 18, 6977–6989.
15. Ferraro L., Beggiato S., Tomasini M. C., Fuxe K., Antonelli T. and Tanganelli S. (2012a) A(2A)/D(2) receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling. Brain Res. 1476, 96–107.
16. Ferraro L., O'Connor W. T., Beggiato S., Tomasini M. C., Fuxe K., Tanganelli S. and Antonelli T. (2012b) Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release–a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat. Eur. J. Neurosci. 35, 207–220.
17. Ferré S., O'Connor W. T., Fuxe K. and Ungerstedt U. (1993) The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13, 5402–5406.
18. Ferre′ S., Popoli P., Rimondini R., Reggio R., Kehr J. and Fuxe K. (1999) Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology 38, 129–140.
19. Fuxe K., Agnati L. F., Jacobsen K. et al. (2003) Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61, S19–S23.
20. Fuxe K., Ferré S., Canals M. et al. (2005) Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J. Mol. Neurosci. 26, 209–220.
21. Fuxe K., Canals M., Torvinen M. et al. (2007) Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural. Transm. 114, 49–75.
22. Fuxe K., Marcellino D., Leo G. and Agnati L. F. (2010) Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. Curr. Opin. Pharmacol. 10, 14–22.
23. Fuxe K., Borroto-Escuela D. O., Romero-Fernandez W., Palkovits M., Tarakanov A. O., Ciruela F. and Agnati L. F. (2014) Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field. Neuropsychopharmacology 39, 131–155.
24. Fuxe K., Guidolin D., Agnati L. F. and Borroto-Escuela D. O. (2015) Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease. Expert Opin. Ther. Targets 19, 377–398.
25. Hettinger B. D., Lee A., Linden J. and Rosin D. L. (2001) Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J. Comp. Neurol. 431, 331–346.
26. Kachroo A., Orlando L. R., Grandy D. K., Chen J. F., Young A. B. and Schwarzschild M. A. (2005) Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J. Neurosci. 25, 10414–10419.
27. Morin N. and Di Paolo T. (2014) Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease. Int. Rev. Neurobiol. 119, 151–167.
28. Morin N., Morissette M., Grégoire L. and Di Paolo T. (2015) mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-Induced Dyskinesias. Curr. Neuropharmacol. DOI 10.2174/1570159X14666151201185652
29. Obeso J. A., Rodríguez-Oroz M. C., Rodríguez M., Lanciego J. L., Artieda J., Gonzalo N. and Olanow C. W. (2000) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23, S8–S19.
30. Paquet M. and Smith Y. (2013) Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J. Neurosci. 23, 7659–7669.
31. Paxinos G. and Watson C. (1982) The rat brain in stereotaxic coordinates. Academic, New York.
32. Pintor A., Pèzzola A., Reggio R., Quarta D. and Popoli P. (2000) The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors. NeuroReport 11, 3611–3614.
33. Popoli P., Pèzzola A., Torvinen M., Reggio R., Pintor A., Scarchilli L., Fuxe K. and Ferré S. (2001) The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 25, 505–513.
34. Reid M. S., O'Connor W. T., Herrera-Marschitz M. and Ungerstedt U. (1990) The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Brain Res. 519, 255–260.
35. Rimondini R., Fuxe K. and Ferré S. (1999) Multiple intramembrane receptor-receptor interactions in the regulation of striatal dopamine D2 receptors. NeuroReport 10, 2051–2054.
36. Schiffmann S. N., Fisone G., Moresco R., Cunha R. A. and Ferré S. (2007) Adenosine A2A receptors and basal ganglia physiology. Prog. Neurobiol. 83, 277–292.
37. Schwarzschild M. A., Agnati L., Fuxe K., Chen J. F. and Morelli M. (2006) Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29, 647–654.
38. Simola N., Morelli M. and Pinna A. (2008) Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions. Curr. Pharm. Des. 14, 1475–1489.
39. Soltis R. P., Anderson L. A., Walters J. R. and Kelland M. D. (1994) A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus. Brain Res. 666, 21–30.
40. Tanganelli S., Sandager Nielsen K., Ferraro L., Antonelli T., Kehr J., Franco R., Ferré S., Agnati L. F., Fuxe K. and Scheel-Krüger J. (2004) Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's disease. Parkinsonism Relat. Disord. 10, 273–280.
41. Yung K. K., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J. and Levey A. I. (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65, 709–730.